Target intelligence / Profile preview

Renal tubular transporter (None (multiple individual transporters have abbreviations such as OAT1, OCT2, etc.))

Target
None (multiple individual transporters have abbreviations such as OAT1, OCT2, etc.)
Molecular classification
Transporter, Carrier protein, Solute carrier (SLC) family member, ATP-binding cassette (ABC) transporter
01

Overview

Renal tubular transporters encompass a group of membrane proteins expressed in the epithelial cells of the kidney's renal tubules, particularly the proximal tubule. Their primary roles are to mediate the secretion and reabsorption of drugs, endogenous metabolites, and toxins. Major transporters include organic anion transporters (OAT1, OAT3), organic cation transporters (OCT2), multidrug and toxin extrusion proteins (MATE1, MATE2-K), P-glycoprotein (P-gp), multidrug resistance-associated proteins (MRP2, MRP4), sodium-glucose cotransporter 2 (SGLT2), and urate transporter 1 (URAT1). These transporters are critical for renal drug clearance, are involved in drug-drug interactions, and can be direct targets or unintended sites of drug action. Their dysfunction or inhibition may contribute to renal disease, altered pharmacokinetics, or drug-induced toxicity[1][2][4][7]. *Note:* To obtain structured information about specific transporters, such as "Organic anion transporter 1 (OAT1)," use their individual full names rather than the generic "Renal tubular transporter."

Other names
Renal drug transporterRenal tubule transporterKidney tubular transporterProximal tubule transporterOrganic anion transporter (OAT)Organic cation transporter (OCT)Multidrug and toxin extrusion protein (MATE)P-glycoprotein (P-gp)Multidrug resistance-associated protein (MRP)Sodium-glucose cotransporter (SGLT2)Urate transporter (URAT1)
02

Mechanism of action

Inhibition of tubular reabsorption (e.g., SGLT2 inhibitors, URAT1 inhibitors) Promotion of drug excretion by blocking reabsorption transporters Blocking cation/anion transport, increasing urine concentration of targeted substrate Inhibition of drug secretion leading to altered drug disposition and toxicity

03

Biological functions

Drug secretionDrug reabsorptionElectrolyte balanceToxin eliminationMetabolite handlingRegulation of solute and water homeostasis
04

Disease associations

NephrotoxicityChronic kidney disease (CKD)Drug-induced kidney injuryRenal cell carcinoma (transporters implicated in pathogenesis and drug response)Hyperuricemia and gout (urate handling)Hypertension (affected via diuretic regulation of solute balance)Other (electrolyte disorders, inherited transporter mutations)
05

Safety considerations

Drug-drug interactions (altered transporter function leading to adverse effects)Nephrotoxicity (direct transporter-mediated toxicity or impaired excretion of nephrotoxic drugs)Genetic polymorphisms altering drug efficacy and riskRenal impairment affecting transporter function and drug disposition
06

Interacting drugs

Diuretics (furosemide, bumetanide, torsemide, hydrochlorothiazide, chlortalidone)

7 more in the full profile.

07

Biomarkers

Creatinine clearance (reflects tubular secretion capacity)Uric acid levels (for URAT1 function and monitoring hyperuricemia/gout therapy)Drug/metabolite urinary excretion profilesRadioisotope renography curves (functional imaging for tubular transporter activity)

Beyond the preview

Go deeper on Renal tubular transporter (None (multiple individual transporters have abbreviations such as OAT1, OCT2, etc.)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal tubular transporter (None (multiple individual transporters have abbreviations such as OAT1, OCT2, etc.)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call